Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
AstraZeneca and Eisai urge UK to remain part of EMA
Big Pharma
UK-headquartered AstraZeneca and Japanese pharmaceutical company Eisai have urged the UK to remain a member of the European Medicines Agency.   9 January 2018
Celgene files TM claim against Beacon over psoriasis drug
Americas
Global biopharmaceutical company Celgene Corporation, headquartered in New Jersey, has filed a claim against oncology company Beacon Pharmaceuticals, situated in Bangladesh, for trademark infringement.   9 January 2018
Celgene to acquire Impact Biomedicines for more than $1bn
Americas
Celgene Corporation is to acquire Impact Biomedicines in the first quarter of 2018.   9 January 2018
Americas
The Patent Trial and Appeal Board has denied an information request by a Native American tribe, deeming it improper for a number of reasons.   8 January 2018
Americas
The US Court of Appeals for the Federal Circuit has handed Apotex a win in a dispute over a tablet coating.   8 January 2018
Americas
Stanford University has entered into a licensing agreement with Madenco Biosciences to develop and commercialise patented epidermal growth factor wound healing technology.   5 January 2018
Americas
Biotech company Arvinas has announced a multi-year research collaboration and licence agreement with global pharmaceutical corporation Pfizer.   5 January 2018
Americas
Litigation-focused firm Robins Kaplan has promoted nine lawyers so far in 2018, including five IP lawyers in its Silicon Valley, Minneapolis, and Boston offices.   5 January 2018
Americas
A Native American tribe that has signed a patent deal with Allergan has requested information on the Patent Trial and Appeal Board judges overseeing inter partes reviews involving the tribe.   4 January 2018
Asia-Pacific
Singapore-based Aslan Pharmaceuticals has acquired the full global rights to develop, manufacture and commercialise a cancer treatment.   4 January 2018